© Watsons. All Right Reserved | Company Reg. No (289892-V)
Kinohimitsu is a proprietary brand under Kino Biotech Co., Ltd. Kino BioTech Co.Ltd is a public listed company in the Taiwan's GreTai Securities Market (GTSM) with its head office in Singapore. This holding company owns 100% stakes in Kino Life Science Ltd, TRN Marketing (M) Sdn Bhd and TRN Marketing Pte Ltd. The Taiwan's GTSM database of public listed companies states that Kino BioTech Co. Ltd has over 4500 points of sales in China, Singapore, Malaysia, Vietnam, Thailand and Indonesia. Their core brands distributed are Kinohimitsu, Activa and Xpertise.
Kino Biotech is a leading integrated bio-nutraceutical and Cosmeceutical Company specialised in product conceptualisation, development, commercialisation, brand marketing, sales and distribution of innovative healthcare and beauty products. The Group’s core business is the sales of healthcare and beauty products under its own proprietary brands – Kinohimitsu, Activa and Expertise.
Kinohimitsu range includes functional drinks, health pads, and healthcare tea products. Kinohimitsu - functional drinks, one of the Group’s popular products among consumers, include D'TOX Juice, BodySlen, JointFlex, ChoLess, MindRelax, Collagen Diamond 5300, Collagen Men 5300, BustUp, Beauty Drink, UV-Bright and BB Drink. A report by The Euromonitor International Research has identified Kinohimitsu as the No. 1 selling beauty and collagen drink across Malaysia and Singapore for three consecutive years from 2008 to 2010.
Kino Biotech takes extra care in choosing ingredients for its products. All ingredients are extracts of 100% pure, natural essences and are free from additives, sugar, artificial colour, preservatives, flavors and hormones. Products are validated and certified by world-recognized health bodies such as SGS International, GMP, and HACCP, including halal certifications. Kinohimitsu won the ‘Best Targeted Health Drinks’ for year 2012 and was the finalist for the ‘Best Alertness Drinks’ by the 8th InnoBev Global Beverages Congress held in London on 21 March 2012.